全球免疫组织化学市场研究报告 - 2023 年至 2030 年行业分析、规模、份额、成长、趋势和预测

全球免疫组织化学市场需求预计将从 2022 年的 51.1 亿美元达到 2030 年近 125.7 亿美元的市场规模，2023-2030 年研究期间复合CAGR为 10.52%。

免疫组织化学 (IHC) 协助诊断和研究实验室识别酵素、肿瘤抑制基因、抗原和肿瘤细胞增生。它包括不同类型细胞中目标蛋白的存在和定位、生物週期甚至复杂组织内的亚细胞定位的可视化。 IHC 在临床诊断中越来越受欢迎，因为它用于诊断癌症、传染病、心血管疾病和自体免疫疾病等慢性疾病。 IHC 用于研究应用，在细胞、分子或组织层面分析感兴趣的分子，以研究它们在健康和患病细胞和组织中的作用。

市场动态：

慢性病的高盛行率预计将增加对免疫组织化学解决方案的需求，从而促进市场成长。此外，人们对更好生活品质的日益关注和医疗保健支出的增加预计将提振市场。此外，IHC技术也用于治疗心臟病、药物开发、传染病、内分泌、药物滥用检测等疾病，为市场带来了推动。此外，该技术在癌症诊断方面发挥了重要作用。因此，癌症盛行率的上升预计将增加对免疫组织化学的需求，从而促进市场成长。然而，IHC 技术缺乏特异性及其高昂的设置成本预计将限制免疫组织化学市场的成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球免疫组织化学市场的每个细分市场进行了包容性评估。免疫组织化学产业的成长和趋势为本研究提供了整体方法。

区域分析：

本节涵盖区域展望，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲免疫组织化学市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。免疫组织化学市场的主要参与者包括Thermo Fisher Scientific Inc.、F. Hoffmann-La Roche Ltd.、Merck KGaA、Danaher Corporation、PerkinElmer, Inc.、Bio-Rad Laboratories, Inc.、Cell Signaling Technology, Inc.、 Bio SB、Abcam plc.、安捷伦科技公司。本部分包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概览、合作、新产品开发、新产品发布，以及其他进展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

• 报告说明
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法论
  • 市场研究过程
  • 市场研究方法论

第 2 章：执行摘要

• 市集亮点
• 全球市场概况

第 3 章：免疫组织化学 - 产业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 产业动态
• 波特五力分析
• 市场吸引力分析
  • 按产品分類的市场吸引力分析
  • 市场吸引力分析：依应用分类
  • 按最终用途分類的市场吸引力分析
  • 市场吸引力分析：按地区

第 4 章：价值链分析

• 价值链分析
• 原料分析
  • 原料清单
  • 原料厂商清单
  • 主要原物料价格走势
• 潜在买家名单
• 行销管道
  • 直效行销
  • 间接行销
  • 行销通路发展趋势

第 5 章：COVID-19 爆发的影响分析

第 6 章：全球免疫组织化学市场分析：按产品

• 按产品概述
• 历史和预测数据
• 按产品分析
• 抗体（一抗、二抗）
• 设备（玻片染色系统、组织微阵列、组织处理系统、玻片扫描器等）
• 试剂（组织学染色剂、封闭血清及试剂、显色底物、固定试剂、稳定剂、有机溶剂、蛋白水解酶、稀释剂、试剂盒）

第 7 章：全球免疫组织化学市场分析：依应用分类

• 概述：按应用
• 历史和预测数据
• 分析：按应用
• 诊断（癌症、传染病、心血管疾病、自体免疫疾病、糖尿病、肾臟病）
• 药物检测

第 8 章：全球免疫组织化学市场销售分析：依最终用途

• 按最终用途分類的概述
• 历史和预测数据
• 按最终用途分析
• 医院和诊断实验室
• 研究机构
• 其他的

第 9 章：全球免疫组织化学市场销售分析：按地理位置

• 区域展望销售分析
• 简介 销售分析
• 北美销售分析
  • 概述、历史和预测销售分析
  • 北美按细分市场销售分析
  • 北美按国家销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概述、历史和预测销售分析
  • 欧洲按细分市场销售分析
  • 欧洲按国家销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 义大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概述、历史和预测销售分析
  • 亚太地区按细分市场销售分析
  • 亚太地区国家/地区销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳洲销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概述、历史和预测销售分析
  • 拉丁美洲按细分市场销售分析
  • 拉丁美洲按国家销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概述、历史和预测销售分析
  • 中东和非洲按细分市场销售分析
  • 中东和非洲国家销售分析
  • 沙乌地阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东其他地区和非洲销售分析

第 10 章：免疫组织化学公司的竞争格局

• 免疫组化市场竞争
• 伙伴关係/协作/协议
• 併购
• 新产品发布
• 其他发展

第 11 章：公司简介

• 十大公司股票分析
• 市场集中度
• Thermo Fisher Scientific Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• F. Hoffmann-La Roche Ltd.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Merck KGaA
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Danaher Corporation
• 公司简介
• 公司收入
• 产品
• 最近的发展
• PerkinElmer Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Bio-Rad Laboratories Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Cell Signaling Technology Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Bio SB
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Abcam plc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Agilent Technologies Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

The global demand for Immunohistochemistry Market is presumed to reach the market size of nearly USD 12.57 BN by 2030 from USD 5.11 BN in 2022 with a CAGR of 10.52% under the study period 2023 - 2030.

Immunohistochemistry (IHC) assists in diagnostic and research laboratories to identify enzymes, tumor suppressor genes, antigens, and tumor cell proliferation. It includes the visualization of the presence and localization of the target protein in different types of cells, biological cycles and even subcellular localization within the complex tissues. IHC has gained popularity in clinical diagnostics as it is used to diagnose chronic diseases such as cancer, infectious diseases, cardiovascular diseases, and autoimmune disorders. IHC is used in research applications where molecules of interest are analyzed on the cellular, molecular, or tissue level to study their roles in both healthy and diseased cells and tissues.

MARKET DYNAMICS:

The high prevalence of chronic diseases is expected to increase demand for immunohistochemistry solutions contributing to market growth. Moreover, the increased concern for experiencing a better quality of life and increased healthcare spending are expected to boost the market. Besides that, the IHC technique is used to treat diseases such as heart disease, drug development, infectious disease, endocrinology, and drug abuse testing, giving the market a boost. Furthermore, the technique has played an important role in shaping cancer diagnostics. As a result, the rising prevalence of cancer is expected to increase the demand for immunohistochemistry, thus contributing to market growth. However, the lack of specificity associated with IHC techniques and its high setup cost is anticipated to restrict the growth of the market for immunohistochemistry.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of immunohistochemistry. The growth and trends of immunohistochemistry industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the immunohistochemistry market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Antibodies (Primary Antibodies, Secondary Antibodies)
• Equipment (Slide Staining System, Tissue Microarrays, Tissue Processing Systems, Slide Scanners, Others)
• Reagents (Histological Stains, Blocking Sera And Reagents, Chromogenic Substrates, Fixation Reagents, Stabilizers, Organic Solvents, Proteolytic Enzymes, Diluents, Kits)

By Application

• Diagnostics (Cancer, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases, Diabetes Mellitus, Nephrological Diseases)
• Drug Testing

By End-Use

• Hospitals & Diagnostic Laboratories
• Research Institutes
• Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Immunohistochemistry market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Immunohistochemistry market include Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, Danaher Corporation, PerkinElmer, Inc., Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., Bio SB, Abcam plc., Agilent Technologies Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . IMMUNOHISTOCHEMISTRY - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By End-use
  • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL IMMUNOHISTOCHEMISTRY MARKET ANALYSIS BY PRODUCT

• 6.1 Overview by Product
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Product
• 6.4 Antibodies (Primary Antibodies, Secondary Antibodies) Historic and Forecast Sales by Regions
• 6.5 Equipment (Slide Staining System, Tissue Microarrays, Tissue Processing Systems, Slide Scanners, Others) Historic and Forecast Sales by Regions
• 6.6 Reagents (Histological Stains, Blocking Sera And Reagents, Chromogenic Substrates, Fixation Reagents, Stabilizers, Organic Solvents, Proteolytic Enzymes, Diluents, Kits) Historic and Forecast Sales by Regions

7 . GLOBAL IMMUNOHISTOCHEMISTRY MARKET ANALYSIS BY APPLICATION

• 7.1 Overview by Application
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Application
• 7.4 Diagnostics (Cancer, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases, Diabetes Mellitus, Nephrological Diseases) Historic and Forecast Sales by Regions
• 7.5 Drug Testing Historic and Forecast Sales by Regions

8 . GLOBAL IMMUNOHISTOCHEMISTRY MARKET SALES ANALYSIS BY END-USE

• 8.1 Overview by End-use
• 8.2 Historical and Forecast Data
• 8.3 Analysis by End-use
• 8.4 Hospitals & Diagnostic Laboratories Historic and Forecast Sales by Regions
• 8.5 Research Institutes Historic and Forecast Sales by Regions
• 8.6 Others Historic and Forecast Sales by Regions

9 . GLOBAL IMMUNOHISTOCHEMISTRY MARKET SALES ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook Sales Analysis
• 9.2. Introduction Sales Analysis
• 9.3. North America Sales Analysis
  • 9.3.1. Overview, Historic and Forecast Sales Analysis
  • 9.3.2. North America By Segment Sales Analysis
  • 9.3.3. North America By Country Sales Analysis
  • 9.3.4. United State Sales Analysis
  • 9.3.5. Canada Sales Analysis
  • 9.3.6. Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1. Overview, Historic and Forecast Sales Analysis
  • 9.4.2. Europe by Segment Sales Analysis
  • 9.4.3. Europe by Country Sales Analysis
  • 9.4.4. United Kingdom Sales Analysis
  • 9.4.5. France Sales Analysis
  • 9.4.6. Germany Sales Analysis
  • 9.4.7. Italy Sales Analysis
  • 9.4.8. Russia Sales Analysis
  • 9.4.9. Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1. Overview, Historic and Forecast Sales Analysis
  • 9.5.2. Asia Pacific by Segment Sales Analysis
  • 9.5.3. Asia Pacific by Country Sales Analysis
  • 9.5.4. China Sales Analysis
  • 9.5.5. India Sales Analysis
  • 9.5.6. Japan Sales Analysis
  • 9.5.7. South Korea Sales Analysis
  • 9.5.8. Australia Sales Analysis
  • 9.5.9. Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1. Overview, Historic and Forecast Sales Analysis
  • 9.6.2. Latin America by Segment Sales Analysis
  • 9.6.3. Latin America by Country Sales Analysis
  • 9.6.4. Brazil Sales Analysis
  • 9.6.5. Argentina Sales Analysis
  • 9.6.6. Peru Sales Analysis
  • 9.6.7. Chile Sales Analysis
  • 9.6.8. Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1. Overview, Historic and Forecast Sales Analysis
  • 9.7.2. Middle East & Africa by Segment Sales Analysis
  • 9.7.3. Middle East & Africa by Country Sales Analysis
  • 9.7.4. Saudi Arabia Sales Analysis
  • 9.7.5. UAE Sales Analysis
  • 9.7.6. Israel Sales Analysis
  • 9.7.7. South Africa Sales Analysis
  • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE IMMUNOHISTOCHEMISTRY COMPANIES

• 10.1. Immunohistochemistry Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11 . COMPANY PROFILES OF IMMUNOHISTOCHEMISTRY INDUSTRY

• 11.1. Top 10 Company Share Analysis
• 11.2. Market Concentration Rate
• 11.3. Thermo Fisher Scientific Inc.
  • 11.3.1. Company Overview
  • 11.3.2. Company Revenue
  • 11.3.3. Products
  • 11.3.4. Recent Developments
• 11.4. F. Hoffmann-La Roche Ltd.
  • 11.4.1. Company Overview
  • 11.4.2. Company Revenue
  • 11.4.3. Products
  • 11.4.4. Recent Developments
• 11.5. Merck KGaA
  • 11.5.1. Company Overview
  • 11.5.2. Company Revenue
  • 11.5.3. Products
  • 11.5.4. Recent Developments
• 11.6. Danaher Corporation
  • 11.6.1. Company Overview
  • 11.6.2. Company Revenue
  • 11.6.3. Products
  • 11.6.4. Recent Developments
• 11.7. PerkinElmer Inc.
  • 11.7.1. Company Overview
  • 11.7.2. Company Revenue
  • 11.7.3. Products
  • 11.7.4. Recent Developments
• 11.8. Bio-Rad Laboratories Inc.
  • 11.8.1. Company Overview
  • 11.8.2. Company Revenue
  • 11.8.3. Products
  • 11.8.4. Recent Developments
• 11.9. Cell Signaling Technology Inc.
  • 11.9.1. Company Overview
  • 11.9.2. Company Revenue
  • 11.9.3. Products
  • 11.9.4. Recent Developments
• 11.10. Bio SB
  • 11.10.1. Company Overview
  • 11.10.2. Company Revenue
  • 11.10.3. Products
  • 11.10.4. Recent Developments
• 11.11. Abcam plc.
  • 11.11.1. Company Overview
  • 11.11.2. Company Revenue
  • 11.11.3. Products
  • 11.11.4. Recent Developments
• 11.12. Agilent Technologies Inc.
  • 11.12.1. Company Overview
  • 11.12.2. Company Revenue
  • 11.12.3. Products
  • 11.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Product (USD MN)
• Antibodies (Primary Antibodies, Secondary Antibodies) Market Sales by Geography (USD MN)
• Equipment (Slide Staining System, Tissue Microarrays, Tissue Processing Systems, Slide Scanners, Others) Market Sales by Geography (USD MN)
• Reagents (Histological Stains, Blocking Sera And Reagents, Chromogenic Substrates, Fixation Reagents, Stabilizers, Organic Solvents, Proteolytic Enzymes, Diluents, Kits) Market Sales by Geography (USD MN)
• Analysis Market by Application (USD MN)
• Diagnostics (Cancer, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases, Diabetes Mellitus, Nephrological Diseases) Market Sales by Geography (USD MN)
• Drug Testing Market Sales by Geography (USD MN)
• Analysis by End-use (USD MN)
• Hospitals & Diagnostic Laboratories Market Sales by Geography (USD MN)
• Research Institutes Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Immunohistochemistry Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Immunohistochemistry Report
• Market Research Process
• Market Research Methodology
• Global Immunohistochemistry Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Product
• Market Attractiveness Analysis by Application
• Market Attractiveness Analysis by End-use
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Product (USD MN)
• Antibodies (Primary Antibodies, Secondary Antibodies) Market Sales by Geography (USD MN)
• Equipment (Slide Staining System, Tissue Microarrays, Tissue Processing Systems, Slide Scanners, Others) Market Sales by Geography (USD MN)
• Reagents (Histological Stains, Blocking Sera And Reagents, Chromogenic Substrates, Fixation Reagents, Stabilizers, Organic Solvents, Proteolytic Enzymes, Diluents, Kits) Market Sales by Geography (USD MN)
• Global Market Analysis by Application (USD MN)
• Diagnostics (Cancer, Infectious Diseases, Cardiovascular Diseases, Autoimmune Diseases, Diabetes Mellitus, Nephrological Diseases) Market Sales by Geography (USD MN)
• Drug Testing Market Sales by Geography (USD MN)
• Global Market Analysis by End-use (USD MN)
• Hospitals & Diagnostic Laboratories Market Sales by Geography (USD MN)
• Research Institutes Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market by Revenue
• North America Market by Revenue
• Europe Market by Revenue
• Asia Pacific Market by Revenue
• Latin America Market by Revenue
• Middle East & Africa Market by Revenue
• Recent Development in Industry
• Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.